Introduction
============

Pancreatic islet β cell tumor, namely insulinoma in clinical, occupies a proportion of 70-80% of pancreatic tumor [@B1],[@B2]. Clinical incidence of insulinoma is about 3-4 per million in the world, presenting a female preponderance [@B3]. Insulinoma can occur in large scope of ages ranging from 8 to 82 years old with a median age of 47 years [@B3]. Commonly, insulinomas locates in intra pancreatic with 10% of malignancy [@B3]. Although the 10 years\' survival rate of insulinomas is about 88 percent after excision, the lesions less than 2 cm account for 90% and the tumor diameter in 50% of patients is less than 1.3 cm [@B4]. So the early diagnosis for insulinoma is still a challenging work for clinical practice. Hypoglycaemia is the secondary common symptom in addition to excessive insulin secretion [@B4]. Chronic hypoglycaemia can definitely result in death. The delayed or mistaken diagnosis of hypoglycaemia and other common symptoms always increase the severity and mortality of insulinomas. Therefore, it is important to early diagnose to reduce the severity and mortality rate.

There are many diagnosis techniques for insulinomas, such as transabdominal ultrasonography, EUS, MRI and CT, etc. Arteriography is rarely used in clinical diagnosis due to its low sensitivity and invasion [@B5],[@B6]. The high sensitivity ranging from 57 to 94 percent has enabled the EUS popular in recent years [@B7],[@B8]. But it has many limitations in evaluation of malignancy and poor differentiation of adjacent lesions [@B9]. The diagnostic sensitivity of CT is also increased as the advent of new advanced technology, and the sensitivity of dual-phase multidetector CT is up to 94 percent though false-negative results are often induced [@B8]. MRI is an accurate tool for detecting the small pancreatic insulinomas and outside metastasis with high sensitivity, but the fee is high and more time is required. For the techniques mentioned above, the early diagnosis, when the tumor nodules are in size less than 1mm, is often difficult. Moreover, the biochemical information at molecular level, which can distinguish the pathological tissues from the adjacent tissues, rarely can be provided from the aforementioned techniques.

Metabonomics, as a part of systems biology, has been used to determine the biochemical changes caused by intrinsic and external factors [@B10],[@B11]. In recent years, metabonomics has been widely used for screening of early metabolic biomarkers in numerous diseases, especially in tumors, such as liver [@B12], breast [@B13], prostate [@B14], pancreas [@B15], kidney [@B16], colorectal [@B17] cancers. Magnetic resonance spectroscopy (MRS) as an important analytical technique has been widely used in metabonomics researches [@B18].

Rip1-Tag2 transgenic mouse is one of animal models of islet β cell tumor, which has been frequently used in studying tumor progression [@B19], inflammation [@B20], regulation of signal pathway [@B21],[@B22] and therapeutic evaluation [@B23]. SV40 large T antigen oncogenes are transplanted to islet cells through an insulin gene promoter, and so some tumor suppressor factors were devitalized and oncogenesis was induced in islet cells [@B20]. A stable and reproducible tumor development in Rip1-Tag2 mice undergoes normal (about 1-3 weeks), hyperplasia (about 4-5 weeks), angiogenic islets (about 6-8 weeks), tumor (about 9-10 weeks) and invasive carcinoma (about 11-14weeks) [@B22],[@B24],[@B25]. The disease progression in Rip1-Tag2 mice is similar with the development of insulinoma in human, and thus this model can be used in detecting dynamic progression and screening out the early diagnostic biomarkers for insulinomas.

In this report, we presented the serum metabolic characteristics of Rip1-Tag2 transgenic mice at five stages to screen out the biomarkers for pathological progression in pancreatic islet β cell cancer, with a view to provide the early diagnostic biomarkers for insulinoma. Pattern recognition analysis was also applied to draw the metabolite characteristics that were specifically associated with implanting of SV40 large T antigen.

Materials and methods
=====================

Rip1-Tag2 mice identification and sample collection
---------------------------------------------------

The Rip1-Tag2 mice \[B6.D2-Tg(RIP1-Tag2)2Dh\] were obtained from Institute of Biochemistry and Cell Biology, SIBS, CAS and were crossed with C57 mice (C57/BL6, Rip1-Tag2 background mice), purchased from Animal Center of Guangdong province (Guangzhou, China). To obtain the targeted Rip1-Tag2 transgenic mice, we identified the gene type with PCR technology. The targeted Rip1-Tag2 product size was about 500bp, shown in lane 1-6 and 10 ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S1). Correspondingly, the 7-9 lanes without 500bp mark represented the background mice C57, as negative control in this study.

Mice were housed in an animal house with controlled temperature (23-24 °C) and humidity (50±10%), on an average light/dark cycle. Rip1-Tag2 mice and C57 mice used in this study were all littermates with no difference between male and female. This research was approved by the Committees for Ethical Review of Research involving Animal Subjects at Guangdong Pharmaceutical University, China. The Rip1-Tag2 mice at 3, 5, 8, 10 and 14 weeks were sacrificed at the indicated time. Blood (approximately 1.5 ml) were collected for serum samples and pancreases and tumor tissues were dissected for histopathological examination.

HE staining
-----------

The fresh tissues were separated and fixed in 4% formalin overnight. After dehydration for about 9 hours, the tissues were embedded in paraffin immediately. Then 4 µm sections were cut and rehydrated after drying in 65 °C dryer for 2 hours. Hematoxylin and eosin were stained after gradient dewaxing.

Sample preparation
------------------

After the serum samples dissolving, 300 μL of each sample was diluted by 150 μL PBS (0.2 M, pH=7.4). The supernatants were transferred into NMR analysis tubes after centrifuging (5000 rpm, 10 min, 4 °C). 80 μL D~2~O was also added to each tube for the deuterium lock.

NMR experiment
--------------

Sera^1^H NMR spectrum was collected on Bruker spectrometer (Avance III 500 MHz). The experimental temperature is 298K. The pulse sequence is CPMG (relaxation delay-90-(τ-180-τ)~n~-acquisition), which was applied to acquire the signals with low molecular weight selectively, with 2nτ of 100 ms and relaxation delay of 2.5 s. 128 scans were collected, data points is 32k and spectral width is 10 kHz.

For signal assignments, 2D spectra of COSY, TOCSY and HSQC were acquired. In COSY and TOCSY experiments, 80 scans with 2048 data points were collected. A MLEV-17 programme was involved in TOCSY experiment with 90 ms mixing time. The spectral width for two dimensions is 10.0 ppm. In HSQC spectra, 120 increments were acquired into 2048 data points, the spectral width for ^1^H and ^13^C is 10.0 ppm and 150.0 ppm, respectively.

Date processing and multivariate analysis
-----------------------------------------

All FID data were Fourier transformed using Bruker Topspin 2.1 software (Bruker, Inc.). ^1^H CPMG spectra at δ 0.50-9.50 were bucketed and automatically integrated using AMIX software (Bruker Biospin, Germany) with integration step of 0.005 ppm. The integral of residual water signal at δ 4.50-5.20 were set to zero. Then the integrals were normalized to the total integrals in one ^1^H spectra.

Pattern recognition analysis was done using SIMICA-P^+^ (Umetric, Umea, Sweden). Intrinsic clusters according to the NMR spectra data was observed by PCA. Sequently, OPLS-DA was performed to establish the group separation for biomarker screening. The scale pattern is unit variance. The results of pattern recognition analysis were visualized by scores plot and loadings plot, where groupings pattern and metabolites differences were shown. The correlation coefficients from OPLS-DA were used to color the variables in loadings plots using a MATLAB programme. The significance of metabolites was further tested by a simple Student\'s test (SPSS 19.0).

Results
=======

Histopathological evaluation of pancreatic islet β cell tumor
-------------------------------------------------------------

Fig. [1](#F1){ref-type="fig"} showed a progressively histopathological assessment in Rip1-Tag2 mice. It was found that proliferation of pancreatic islet β cells started at about 5 weeks with distinctly accumulated islet cells and enlarged volume compared to the morphological feature at 3 weeks. At about 8 weeks, angiogenic islets characterized by endothelial proliferation, vascular dilation, and microhemorrhagin was prevalent and then solid tumors emerged after soon. From the morphological feature at 10 weeks, we can find that the tumors were encapsulated and clear boundary from the surrounding tissue appeared, with a little tendency of microinvasion. Up to 14 weeks, invasive carcinoma commonly appeared in features of obvious atypia of islet structure and invasiveness with surrounding tissue. And both of tumor and invasive carcinoma were intensively vascularized by dilated blood vessels.

Serum^1^H CPMG Spectroscopy
---------------------------

Five typical sera ^1^H CPMG spectra from C57 (Fig. [2](#F2){ref-type="fig"}A) and Rip1-Tag2 mice at hyperplasia (Fig. [2](#F2){ref-type="fig"}B, 5 weeks), angiogenic islets (Fig. [2](#F2){ref-type="fig"}C, 8 weeks), tumor (Fig. [2](#F2){ref-type="fig"}D, 10 weeks) and invasive carcinoma (Fig. [2](#F2){ref-type="fig"}E, 14 weeks) stages were shown in Fig. [2](#F2){ref-type="fig"}, respectively. There are nearly no variability in metabolite composition and chemical shift perturbation among these spectra. The peaks were assigned on the basis of the published data [@B26]-[@B27] and determined by two dimension spectroscopy. The CPMG pulse sequence highlighted the smaller molecules through editing out those broad resonances. No obvious differences between the five groups were found visually due to the individual variability. Therefore, all the samples must be analyzed together by use of multivariate data analysis in order to get meaningful metabolites for different groups.

Sera metabolic phenotype in Rip1-Tag2 mice
------------------------------------------

We compared the sera metabolic profiles in morphologically normal Rip1-Tag2 mice (3 weeks old) and background mice of C57, in order to discover the metabolic difference induced by SV 40 gene transplantation. PCA was firstly done according to the ^1^H NMR integral data at δ 0.5-4.5 in order to highlight the contribution of metabolites with low molecular weight (in [Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S2), in which obvious separation between these two types of mice was observed, demonstrating the distinct metabolic phenotype associated with SV 40 gene transplantation in Rip1-Tag2 mice. Clear grouping between Rip1-Tag2 and C57 through t~1~ dimension was also found in OPLS-DA model (Fig. [3](#F3){ref-type="fig"}A, R^2^X=88.5%, Q^2^Y=78.3%). We can observe that lactate, LDL+VLDL and choline increased, and acetate, glucose, taurine, glycine and myo-inositol decreased in Rip1-Tag2 transgenic mice (Fig. [3](#F3){ref-type="fig"}B). All the selected metabolites showed statistical significance between Rip1-Tag2 and C57 mice, which may serve as biomarkers associated with SV 40 gene transplantation in Rip1-Tag2 mice (Table [1](#T1){ref-type="table"}).

Metabolic Variations Associated with Tumor Progression
------------------------------------------------------

The PCA model was constructed to classify the Rip1-Tag2 sera samples at different stages. In Fig. [4](#F4){ref-type="fig"}, an obvious distribution trajectory was displayed with R^2^of 82.8% and Q^2^ of 79.3% as the arrow showed. It was noted that there was serious overlapping between the samples at 3 weeks and 5 weeks. By looking at the ^1^H spectra of these two groups, we speculated that this distribution pattern came from the similarity in ^1^H spectra profiles. This original differentiation tendency demonstrated the dynamic metabolic variations correlated with the development of pancreatic islet β cell carcinoma. Therefore, the serum metabolic characteristics reveal the metabonomic perturbations along with the pathological progress.

In this research, OPLS-DA models were built among the samples at different stages to find the potential biomarkers characterizing the histopathological progression. Scores and loadings line plots coded with coefficients were presented. The metabolites with significant contribution to the differentiation between two groups were hot colored. We didn\'t perform multivariate analysis on the spectra data at 5 weeks because of the metabolic similarity with the ones at 3 week. Fig. [5](#F5){ref-type="fig"}A1 showed the distinct grouping cluster between samples at 3 weeks and the ones at 8 weeks, which revealed the obvious sera metabolic changes in Rip1-Tag2 mice at angiogenic islets stage. It was found that lactate was up-regulated, while acetate, dimethylamine, taurine, glucose and myo-inositol were decreased in the serum samples at 8 weeks (Fig. [5](#F5){ref-type="fig"}B1). The same OPLS-DA strategy was also used to the metabonome between 3 weeks and 10 weeks, which showed the clear differentiation between them. In addition to the metabolites changes mentioned above, a series of new metabolites with notable changes appeared at the early stage of tumor, including alanine, methionine, citrate and choline. The variation trend of metabolites contributing to the favorable classification between 3 weeks and 14 weeks (Fig. [5](#F5){ref-type="fig"}B3) were generally in consistent with the changes at 10 weeks, except the changes of glutamate and glycine at 14 weeks. It was noted from the scores plots that the differentiation from the samples at 14 weeks became greater with the aggravation of pathological progression, which indicated that more important metabolites variations appeared with tumor development. The statistical analysis results were showed in table [2](#T2){ref-type="table"}. It was observed that changes in lactate, dimethylamine and myo-inositol started to change with statistical significance at 8 weeks, when angiogenic islets emerged. The significantly increased methionine, citrate, choline, and the decreased acetate, taurine and glucose firstly appeared at the early stage of pancreatic islet β cell tumor. Therefore, these metabolites could be regarded as potential biomarkers of tumorigenesis. Moreover, the emerging of statistically elevated alanine and glutamate, as well as the decreased glycine were metabolic characteristics for invasive carcinoma in Rip1-Tag2 mice.

Discussion
==========

In this study, metabonomics is first used to explore the association between the development of pancreatic islet β cell carcinoma and metabonomic disorders, and discover the metabolic phenotype associated with SV 40 gene transplantation in Rip1-Tag2 mice. Therefore, serum metabonomics was performed to screen biochemical markers for the development of pancreatic islet β cell tumor, which will be valuable for the early diagnosis of insulinomas.

From the histopathological characteristics shown in Fig. [1](#F1){ref-type="fig"}, we could find the noticeable progression of tumor development, and the histopathological changes in every stage showed great reproducibility and were consistent with the previous results [@B22], [@B24], [@B25]. Fig. [4](#F4){ref-type="fig"} demonstrated the metabolic progression trajectory from 3 weeks to 14 weeks, which revealed the serum metabolic changes with the tumor development. However, the samples at 3 weeks and 5 weeks were inseparable due to few metabolic differences between normal and proliferation stages, which may be a result of slight proliferation of pancreatic islet β cells at 5 weeks. Multivariate data analyses were performed to identify the metabonomic biomarkers for characterizing the different stages of tumor development. By comparing with sera metabonomic profiles in different types of tumor [@B28]-[@B33], it was found that the increased methionine, and decreased DMA, taurine, glycine and MI were unique characteristics of the serum metabolic profiles in Rip1-Tag2 mice. A general metabolic pathway was drawn according to the changed metabolites (Fig. [6](#F6){ref-type="fig"}), in which mechanism of glucose, lipid, choline and amino acid were obviously displayed and the mutual transformations between each other were shown in general.

Glucose metabolism is important in the energy supply of whole body. The reduced level of glucose and the elevated lactate were observed in Rip1-Tag2 mice compared to C57 mice, from which we speculated that transplantation of SV 40 gene induced the glucose metabolism changes. Meanwhile, we also found that the level of lactate increased throughout the whole stages of pathological progress in Rip1-Tag2 mice with an accentuated trend (shown in Fig. [5](#F5){ref-type="fig"}). The metabolic change of glucose and lactate may indicate the time-dependent activation of anaerobic glycolysis, which provided the most energy to meet the energy requirement of the whole body. Furthermore, the increased citrate, one of the most important intermediates in TCA cycle, was also observed during the tumor progression from 10 week to 14 weeks. The accumulated citrate may suggest the disturbance in energy metabolism and the mitochondrial dysfunction as the progression advanced. Insulin, serving as a messenger, can promote muscle and adipose tissue to uptake glucose and provide convenience for anaerobic and aerobic glycolysis [@B18]. As the increased secretion of insulin in Rip1-Tag2 mice along with the progression advanced, it was found that both the anaerobic glycolysis and aerobic oxidation were enhanced, so the reduced glucose and accumulated of lactate and citrate were observed subsequently. Moreover, the emerging of increased lactate firstly appeared at angiogenic islets stage, which possibly suggested that excessive lactate from glycolysis as a result of increased energy demand at angiogenic islets stage. Hypoglycemia is usually common in insulinoma, and the reason accounting for this phenomenon is probably hypersecretion of insulin [@B34] and the activated glucose metabolism from great energy requirement. The increased lactate was also found in esophageal cancer, which demonstrated the activated glucose metabolism by way of glycolysis from aggressive proliferation of tumor cells [@B31]. However, it was found that the down-regulated TCA metabolism existed in colorectal cancer [@B33], a possible result of different type of tumor.

Choline, involved in the phospholipid metabolism, has ever been identified as a common metabolic change in tumorigenic development [@B35], [@B36]. In this study, the up-regulated of choline was one of the serum metabolic characteristics in Rip1-Tag2 mice associated with SV 40 gene. The significant increase of choline was also found at the tumor formation and invasion metastasis stage, which revealed the metabolic change of choline is an early biomarker for tumor formation and development for pancreatic islet β cell carcinoma. The possible molecular mechanisms for choline metabolism may include up-regulated choline kinase [@B37], accelerated choline transportation [@B38] and elevated PLD [@B39] and PLA2 activity [@B40]. Meanwhile, coupling with the involvement of the tumor growth factors, oncogenes and chemical carcinogens, the activity of choline kinase was enhanced throughout the tumor progression [@B41]. The role of choline kinase has been demonstrated by many studies, one of which had reported that the choline kinase was over expressed in breast tumor in contrast to normal breast and it had been evidenced to have great association with breast tumor stage [@B42]. However, there is a decreased level in choline in ovarian cancer, which revealed the disturbance of choline metabolism [@B28]. Microbial flora was possibly involved in the choline metabolism from the decreased dimethylamine, as a choline metabolite mediated by microbiota. Dimethylamine started to reduce at the angiogenic islets stage, and continuously decreased at tumor formation and invasive carcinoma stage of Rip1-Tag2 mice. This result revealed the increased choline level as a result of the reduced metabolism and activated synthesis of choline. Moreover, the change of choline metabolism at angiogenic islets stage is prior to the change of synthesis pathway. Additionally, the decrease of dimethylamine possibly suggested that gut microbiota disorders was involved in the progression of pancreatic islet β cell tumor. However, this needs to be testified by further research.

Insulin is an essential substance to supply amino acids for gluconeogenesis. Study had reported that impaired insulin secretion could directly promote the gluconeogenesis and induce the up-regulation of glucose [@B43]. The amino acids of methionine, glutamate, and alanine were markedly increased at tumor stage in Rip1-Tag2 mice. The excessive secretion of insulin probably restrained the gluconeogenesis and promoted the transformation from glucose to amino acids. In addition, amino acid transporters were reported to be up-regulated in cancer cells, which could contribute to the accumulation of amino acids [@B44]. The increased amino acids also reflected the fact that the structural proteins were highly demanded during tumor cells proliferation and apotosis.

Taurine, a sulfur-containing amino acid, also showed significant decrease in the process of tumor growth. In previous studies, taurine has been regarded as biomarker for bladder carcinoma [@B45] and endometrial cancer [@B46], as well as a stable marker for tumor cell apoptosis in astrocytomas of human [@B47]. In our present study, we found the continuously decreased taurine in sera samples of Rip1-Tag2 mice, which was in consistent with the result in patients of breast cancer [@B48]. Diverse function of taurine in the body had been explored, which included intracellular osmoregulation [@B49], antioxidant activity [@B50] and bile acid formation [@B51]. The reduced taurine possibly indicated the disorder in one or all of the mentioned functions.

Myo-inositol, as a source of second messengers, is a precursor in the phosphatidylinositol metabolism. In this study, the level of myo-inositol was found to decline constantly in the progression of the pancreatic islet β cell carcinoma. This result implied myo-inositol might be a biomarker in the hemorrhagic pancreas period, and it might correlate with the malignant degree of the pancreatic islet β cell carcinoma.

Conclusion
==========

In summary, our findings presented that NMR-based metabonomics has the power to identify biomarkers that correlated with the tumor progression in Rip1-Tag2 mice. There are early decreases in myo-inositol and dimethylamine, and increase in lactate concentrations that occur at the angiogenic islets stage. The activated energy and amino acid metabolism were found at the early stage of tumor formation. The notable changes in alanine, glutamate and glycine were characteristics in metabolic profiles at invasive carcinoma stage. Additionally, this approach has been extended to determine the metabolic phenotype associated with gene alterations in Rip1-Tag2 mice, which potentially regarded as surrogates for the genetic event.
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![Representative images of HE stainings of pancreatic and tumor tissues from Rip1-Tag2 mice at different stages (3, 5, 8, 10 and 14 weeks).](ijbsv11p0595g001){#F1}

![500MHz sera ^1^H CPMG NMR spectra from C57 (A, 3 weeks) and Rip1-Tag2 mice (B, 5 weeks; C,8 weeks; D,10 weeks; E,14 weeks). Note: 1. lipid (mainly LDL and VLDL); 2. isoleucine (Ile); 3. leucine (Leu); 4. valine (Val); 5. lactate (Lac); 6. alanine (Ala); 7. acetate (Ace); 8. methionine (Met); 9.glutamate (Glu); 10. pyruvate (Pyr); 11.glutamine (Gln); 12.citrate (Cit); 13.dimethylamine (DMA); 14. creatine (Cr); 15.choline (Cho); 16. glycerophosphocholine + phosphocholine (GPC+PC); 17. taurine (Tau); 18. Trimethylamine-N-oxide (TMAO) and Betaine (Bet); 19. glycine (Gly); 20. threonine (Thr); 21. myo-inositol (MI); 22. α-glucose (α-Glc); 23. β-glucose (β-Glc); 24. unsaturated lipid; 25. tyrosine (Tyr); 26. 1-methylhistidine; 27. phenylalanine; 28. formate.](ijbsv11p0595g002){#F2}

![OPLS-DA scores and coefficient-colored loadings plots (A, B) for 3 weeks-old C57 mice (■) and Rip1-Tag2 (●). (R^2^X=88.5%, Q^2^Y=78.3%)](ijbsv11p0595g003){#F3}

![PCA Scores plot of sera ^1^H NMR data in Rip1-Tag2 mice at different pathological stage (R^2^=82.8%, Q^2^=79.3%). 3 weeks (●), 5 weeks (●), 8 weeks (◆), 10 weeks (■) and 14 weeks (▲).](ijbsv11p0595g004){#F4}

![OPLS-DA analysis results of sera ^1^H CPMG NMR data in Rip1-Tag2 mice at 3 weeks (●), 8 weeks (◆), 10 weeks (■) and 14 weeks (▲). A, scores plots; B, coefficient-coded loadings plots. A1, B1: 8 weeks vs 3 weeks, R^2^X=68.5%, Q^2^Y=57.3%; A2, B2: 10 weeks vs 3 weeks, R^2^X=76.1%, Q^2^Y=69.3%; A3, B3: 14 weeks vs 3 weeks, R^2^X=89.5%, Q^2^Y=80.7%.](ijbsv11p0595g005){#F5}

![A summary of the biochemical pathway changes in the pathological progression of Rip1-Tag2 transgenic mice. Blue represents the changes at 8 weeks, green represents the changes at 10 weeks and orange represents the changes at 14 weeks.](ijbsv11p0595g006){#F6}

###### 

Sera metabolites changes in Rip1-Tag2 mice at 3 weeks.

  Metabolites   δ^1^H (ppm)   Rip1-Tag2 vs C57
  ------------- ------------- ------------------
  LDL/VLDL      0.89,1.27     ↑\*
  Ace           1.92          ↓\*
  Lac           1.33,4.11     ↑\*\*
  Cho           3.20          ↑\*
  Glc           3.40-3.90     ↓\*
  Tau           3.43          ↓\*\*
  Gly           3.57          ↓\*
  MI            3.53,3.63     ↓\*

↑, denotes increased changes; ↓, denotes decreased changes; -, no statistical change; ^\*^ in comparison with C57.^\*^*p*\<0.05; ^\*\*^*p*\<0.01.

###### 

The potential biochemical markers were statistically analyzed at different stages of Rip1-Tag2 mice.

  Metabolites   δ^1^H (ppm)   8 week   10 week   14 week
  ------------- ------------- -------- --------- ---------
  Lac           1.33,4.11     ↑\*      ↑\*\*     ↑\*\*\*
  Ala           1.48          \-       \-        ↑\*\*
  Ace           1.92          \-       ↓\*       ↓\*\*
  Met           2.13          \-       ↑\*       ↑\*
  Glu           2.14          \-       \-        ↑\*\*
  Cit           2.52,2.72     \-       ↑\*       ↑\*\*
  DMA           2.71          ↓\*      ↓\*       ↓\*\*\*
  Cho           3.20          \-       ↑\*       ↑\*\*
  Tau           3.26,3,43     \-       ↓\*\*     ↓\*\*\*
  Glc           3.40-3.90     \-       ↓\*       ↓\*\*
  Gly           3.57          \-       \-        ↓\*\*
  MI            3.53,3.63     ↓\*      ↓\*\*     ↓\*\*\*

↑, denotes increased changes; ↓, denotes decreased changes; -, no statistical change; ^\*^ in comparison with Rip1-Tag2 mice at 3 weeks. ^\*^*p*\<0.05; ^\*\*^*p*\<0.01;^\*\*\*^*p*\<0.001.
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